EAM Investors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
EAM Investors's VCYT Position: Q3 2026 in Review
EAM Investors sold out of Veracyte (VCYT) in Q3 2026, closing a stake of 68,609 shares — an estimated $4.03M sold.
EAM Investors first reported a position in VCYT in Q2 2015 and held it in 11 quarters. The position peaked at $4.92M in Q1 2019. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- EAM Investors reported no remaining Veracyte position as of Q3 2026 after selling out during the quarter.
- EAM Investors sold 68,609 Veracyte shares in Q3 2026, an estimated $4.03M.
- EAM Investors first reported a position in Veracyte in Q2 2015 and held it in 11 quarters.
- EAM Investors's Veracyte position peaked at $4.92M in Q1 2019.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on EAM Investors's 13F filing for Q3 2026, filed 16 Nov 2026.